244 related articles for article (PubMed ID: 21068204)
21. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
22. Consumption patterns and biomarkers of exposure in cigarette smokers switched to Snus, various dissolvable tobacco products, Dual use, or tobacco abstinence.
Krautter GR; Chen PX; Borgerding MF
Regul Toxicol Pharmacol; 2015 Mar; 71(2):186-97. PubMed ID: 25549549
[TBL] [Abstract][Full Text] [Related]
23. A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.
Meier E; Lindgren BR; Anderson A; Reisinger SA; Norton KJ; Jensen J; Strayer L; Dick L; Tang MK; Chen M; Carmella SG; Hecht SS; Murphy SE; Yang J; Stepanov I; O'Connor RJ; Shields PG; Hatsukami DK
Nicotine Tob Res; 2020 Apr; 22(4):473-481. PubMed ID: 31321423
[TBL] [Abstract][Full Text] [Related]
24. Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products.
Stepanov I; Carmella SG; Briggs A; Hertsgaard L; Lindgren B; Hatsukami D; Hecht SS
Cancer Res; 2009 Nov; 69(21):8236-40. PubMed ID: 19843845
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers.
Sarkar M; Wang J; Liang Q
Drug Metab Lett; 2012 Sep; 6(3):198-206. PubMed ID: 23140558
[TBL] [Abstract][Full Text] [Related]
27. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers.
Caraway JW; Chen PX
Nicotine Tob Res; 2013 Mar; 15(3):670-7. PubMed ID: 22990227
[TBL] [Abstract][Full Text] [Related]
28. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
[TBL] [Abstract][Full Text] [Related]
29. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Cobb CO; Foulds J; Yen MS; Veldheer S; Lopez AA; Yingst JM; Bullen C; Kang L; Eissenberg T;
Lancet Respir Med; 2021 Aug; 9(8):840-850. PubMed ID: 33857436
[TBL] [Abstract][Full Text] [Related]
30. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users.
Post A; Gilljam H; Rosendahl I; Bremberg S; Galanti MR
Addiction; 2010 Apr; 105(4):740-6. PubMed ID: 20148785
[TBL] [Abstract][Full Text] [Related]
31. Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes.
Pulvers K; Emami AS; Nollen NL; Romero DR; Strong DR; Benowitz NL; Ahluwalia JS
Nicotine Tob Res; 2018 Jan; 20(2):206-214. PubMed ID: 28003511
[TBL] [Abstract][Full Text] [Related]
32. Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.
Rostron BL; Chang CM; van Bemmel DM; Xia Y; Blount BC
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1829-37. PubMed ID: 26582044
[TBL] [Abstract][Full Text] [Related]
33. Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations.
Cassidy RN; Colby SM; Tidey JW; Jackson KM; Cioe PA; Krishnan-Sarin S; Hatsukami D
Drug Alcohol Depend; 2018 Jul; 188():153-160. PubMed ID: 29775959
[TBL] [Abstract][Full Text] [Related]
34. Toxicant exposure in cigarette reducers versus light smokers.
Hatsukami DK; Le CT; Zhang Y; Joseph AM; Mooney ME; Carmella SG; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2355-8. PubMed ID: 17164356
[TBL] [Abstract][Full Text] [Related]
35. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
36. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
37. Snus users had high levels of nicotine, cotinine and 3-hydroxycotinine in their breastmilk, and the clearance was slower than in smoking mothers.
Nordenstam F; Lundell B; Edstedt Bonamy AK; Raaschou P; Wickström R
Acta Paediatr; 2019 Jul; 108(7):1250-1255. PubMed ID: 30276861
[TBL] [Abstract][Full Text] [Related]
38. Perceived Health Risks of Snus and Medicinal Nicotine Products.
Hatsukami DK; Vogel RI; Severson HH; Jensen JA; O'Connor RJ
Nicotine Tob Res; 2016 May; 18(5):794-800. PubMed ID: 26386473
[TBL] [Abstract][Full Text] [Related]
39. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
Walele T; Sharma G; Savioz R; Martin C; Williams J
Regul Toxicol Pharmacol; 2016 Feb; 74():193-9. PubMed ID: 26702788
[TBL] [Abstract][Full Text] [Related]
40. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Murphy SE; Link CA; Jensen J; Le C; Puumala SS; Hecht SS; Carmella SG; Losey L; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1617-23. PubMed ID: 15466978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
